Safety alertSource: FDA Drug Enforcement Reports

Class II recall: Novartis Pharmaceuticals Corporation: Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufac

The FDA has classified as a Class II recall a batch of Novartis Pharmaceuticals' Diovan (valsartan) 160 mg tablets, 90-count bottles, NDC 0078-0359-34, manufactured by Patheon Manufacturing Services LLC and distributed by Novartis Pharmaceutical Corp. The recall was issued because the product failed dissolution specifications, according to the FDA recall notice.

Most relevant for: patients taking Diovan (valsartan) 160 mg from the recalled batch who have hypertension or heart disease requiring angiotensin II receptor blocker therapy

Read the original at FDA Drug Enforcement Reports

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.

Specialties

More internal medicine updates

Get updates for your specialty